Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab
Nijhof, I S, Groen, R W J, Lokhorst, H M, van Kessel, B, Bloem, A C, van Velzen, J, de Jong-Korlaar, R, Yuan, H, Noort, W A, Klein, S K, Martens, A C M, Doshi, P, Sasser, K, Mutis, T, van de Donk, N W C J
Published in Leukemia (01.10.2015)
Published in Leukemia (01.10.2015)
Get full text
Journal Article
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
van de Donk, N. W. C. J., Mutis, T., Poddighe, P. J., Lokhorst, H. M., Zweegman, S.
Published in International journal of laboratory hematology (01.05.2016)
Published in International journal of laboratory hematology (01.05.2016)
Get full text
Journal Article
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma
Franssen, L E, Roeven, M W H, Hobo, W, Doorn, R, Oostvogels, R, Falkenburg, J H F, van de Donk, N W, Kester, M G D, Fredrix, H, Westinga, K, Slaper-Cortenbach, I, Spierings, E, Kersten, M J, Dolstra, H, Mutis, T, Schaap, N, Lokhorst, H M
Published in Bone marrow transplantation (Basingstoke) (01.10.2017)
Published in Bone marrow transplantation (Basingstoke) (01.10.2017)
Get full text
Journal Article
Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis
Slot, S, Smits, K, van de Donk, N W C J, Witte, B I, Raymakers, R, Janssen, J J W M, Broers, A E C, Te Boekhorst, P A W, Zweegman, S
Published in Bone marrow transplantation (Basingstoke) (01.11.2015)
Published in Bone marrow transplantation (Basingstoke) (01.11.2015)
Get full text
Journal Article
Case report: persistently seronegative neuroborreliosis in an immunocompromised patient
Wagemakers, A, Visser, M C, de Wever, B, Hovius, J W, van de Donk, N W C J, Hendriks, E J, Peferoen, L, Muller, F F, Ang, C W
Published in BMC infectious diseases (02.08.2018)
Published in BMC infectious diseases (02.08.2018)
Get full text
Journal Article
The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs
Franssen, L E, van de Donk, N W C J, Emmelot, M E, Roeven, M W H, Schaap, N, Dolstra, H, Hobo, W, Lokhorst, H M, Mutis, T
Published in Bone marrow transplantation (Basingstoke) (01.06.2015)
Published in Bone marrow transplantation (Basingstoke) (01.06.2015)
Get full text
Journal Article
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
VAN DE DONK, N. W. C. J, KRÖGER, N, AYUK, F. A, VAN OERS, M. H. J, NAGLER, A, VERDONCK, L. F, LOKHORST, H. M, HEGENBART, U, CORRADINI, P, SAN MIGUEL, J. F, GOLDSCHMIDT, H, PEREZ-SIMON, J. A, ZIJIMANS, M, RAYMAKERS, R. A, MONTEFUSCO, V
Published in Bone marrow transplantation (Basingstoke) (01.06.2006)
Published in Bone marrow transplantation (Basingstoke) (01.06.2006)
Get full text
Journal Article
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
MINNEMA, M. C, VAN DE DONK, N. W. C. J, ZWEEGMAN, S, HEGENBART, U, SCHONLAND, S, RAYMAKERS, R, ZIJLMANS, J. M. J. M, KERSTEN, M. J, BOS, G. M. J, LOKHORST, H. M
Published in Bone marrow transplantation (Basingstoke) (01.05.2008)
Published in Bone marrow transplantation (Basingstoke) (01.05.2008)
Get full text
Journal Article
P1739: HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN‐LABEL DOSE ESCALATION STUDY
Donk, N. W., Guo, S., Shi, L., Lord‐Bessen, J., Tang, D., Karlin, L., Weisel, K., Ramasamy, K., Abad, P. C., Amin, A., Amin, S., Lonial, S.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P865: BIOMARKER ANALYSIS TO SUPPORT DOSE OPTIMIZATION OF IBERDOMIDE AS MONOTHERAPY AND IN COMBINATION WITH STANDARD OF CARE TREATMENTS FOR MULTIPLE MYELOMA FROM A PHASE 1/2 TRIAL
Amatangelo, M., Cheng, Y., Pierceall, W., Donk, N. W., Lonial, S., Wang, M., Emerson, J., Hong, K., Maciag, P., Peluso, T., Gandhi, A., Thakurta, A.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY
Einsele, H., Moreau, P., Delforge, M., Donk, N. W., Ghilotti, F., Diels, J., Elsada, A., Strulev, V., Pei, L., Kobos, R., Smit, J., Slavcev, M., Weisel, K., Mateos, M.‐V.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
PB2014: TECLISTAMAB VS SELINEXOR‐DEXAMETHASONE IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING‐ADJUSTED INDIRECT COMPARISON
Rosinol, L., Usmani, S. Z., Bahlis, N., Krishnan, A. Y., Nooka, A. K., Oriol, A., Delforge, M., Garfall, A. L., Donk, N. W., Rodríguez Otero, P., Martin, T. G., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Moreau, P.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC‐1
Martínez‐López, J., Moreau, P., Usmani, S. Z., Garfall, A., Donk, N. W., San‐Miguel, J. F., Oriol, A., Chari, A., Karlin, L., Mateos, M.‐V., Popat, R., Nooka, A. K., Sidana, S., Trancucci, D., Verona, R., Girgis, S., Uhlar, C., Stephenson, T., Banerjee, A., Krishnan, A.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P958: REAL‐LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSES FROM THE LOCOMMOTION STUDY
Einsele, H., Moreau, P., De Stefano, V., Dytfeld, D., Angelucci, E., Benjamin, R., Goldschmidt, H., Donk, N. W., Besemer, B., Scheid, C., Vij, R., ’. Groen‐Damen, E. I., Semerjian, M., Strulev, V., Schecter, J. M., Roccia, T., Nesheiwat, T., Wapenaar, R., Weisel, K., Mateos, M.‐V.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P922: HEALTH‐RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B‐CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC‐1
Popat, R., Moreau, P., Usmani, S. Z., Garfall, A., Mateos, M.‐V., San‐Miguel, J. F., Oriol, A., Nooka, A. K., Rosinol, L., Chari, A., Karlin, L., Krishnan, A., Bahlis, N., Martin, T., Besemer, B., Martínez‐López, J., Delforge, M., Fastenau, J., Gries, K. S., Donk, N. W.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING‐ADJUSTED INDIRECT TREATMENT COMPARISON
Delforge, M., Usmani, S. Z., Donk, N. W., Garfall, A. L., Moreau, P., Oriol, A., Nooka, A. K., Rosinol, L., Bahlis, N., Rodriguez‐Otero, P., Martin, T., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Krishnan, A.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
S185: CARTITUDE‐2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY
Agha, M. E., Donk, N. W., Cohen, A. D., Cohen, Y. C., Anguille, S., Kerre, T., Roeloffzen, W., Schecter, J. M., De Braganca, K. C., Varsos, H., Mistry, P., Roccia, T., Zudaire, E., Corsale, C., Akram, M., Geng, D., Nesheiwat, T, Pacaud, L., Sonneveld, P., Zweegman, S.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article